To confirm a diagnosis of coeliac disease in a patient presenting with gastrointestinal symptoms, the following serological tests should be ordered:
- First-choice tests: Laboratories should test for total immunoglobulin A (IgA) and IgA tissue transglutaminase (tTG) as the first choice for both young people, adults, and children NICE NG20.
- For weakly positive IgA tTG (young people and adults): If IgA tTG is weakly positive, IgA endomysial antibodies (EMA) should be used NICE NG20.
- For IgA deficiency: If IgA is deficient (defined as total IgA less than 0.07 g per litre), consider using IgG EMA, IgG deamidated gliadin peptide (DGP), or IgG tTG NICE NG20. A specific assay designed to measure total IgA levels should be used when testing for total IgA NICE NG20.
Tests not to use for initial diagnosis in non-specialist settings: Do not use human leukocyte antigen (HLA) DQ2 (DQ2.2 and DQ2.5)/DQ8 testing in the initial diagnosis of coeliac disease in non-specialist settings NICE NG20.
Important pre-test advice: For any serological test to be accurate, the patient must be eating a gluten-containing diet during the diagnostic process NICE NG20. Patients should be advised to eat some gluten in more than one meal every day for at least six weeks before testing NICE NG20. It is crucial that patients do not start a gluten-free diet until diagnosis is confirmed by a specialist, even if serological test results are positive NICE NG20.